API and HPAPI Industry List of Key Emerging Companies, Technology Disruptors, and Innovators

Posted on 2023-07-12 by researchinsights in Healthcare, Industrial, Pharmaceuticals, Technology // 0 Comments

Active Pharmaceutical Ingredients and High Potency API Industry Data Book – Active Pharmaceutical Ingredients and High Potency Active Pharmaceutical Ingredients Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 – 2030

Grand View Research’s API and High Potency API industry databook is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.The following data points will be included in the final product offering in two reports and one sector report overview.

Access the Global API and High Potency API Industry Data Book, 2023 to 2030, compiled with details like trade data, pricing intelligence, and competitive benchmarking.

API Market Report Highlights

The global active pharmaceutical ingredients market was valued at USD 209.71 billion in 2021 and is anticipated to witness growth at a rate of 5.9% over the forecast period.

Innovative APIs held the largest share of 47.07% in 2022, owing to increasing research and development activities for novel drug development and positive government initiatives
The cardiovascular disease segment held the largest revenue share of 21.54% in 2022, attributed to the rising prevalence of target disease globally
The synthetic API segment dominated the market with the largest revenue share of 72.6% in 2021, owing to the higher availability of raw materials and easier protocols for the synthesis of these molecules
North America accounted for the largest revenue share of 38.80% in 2021 and is expected to maintain its lead over the forecast period. This is attributed to the rising epidemiology of cancer, along with other lifestyle-induced diseases, thus encouraging the R&D activities, thereby boosting the market growth

Top Players Operating in the API Market, 2021

Order your copy of Free Sample of “Active Pharmaceutical Ingredients and High Potency API Industry Data Book – Active Pharmaceutical Ingredients and High Potency Active Pharmaceutical Ingredients Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 – 2030” Data Book, published by Grand View Research

HPAPI Market Report Highlights

The global high potency API market was valued at USD 23.60 billion in 2021 and is anticipated to witness growth at a rate of 6.2% over the forecast period.

In 2022, synthetic segment held a dominant share in the HPAPI market owing to its easier synthesis and effectiveness in treatment offered by synthetic HPAPI
Outsourced segment is projected to grow at the fastest rate over the forecast period owing to the increasing adoption of outsourcing of HPAPI
Innovative HPAPI segment is the highest revenue-generating segment in 2022 owing to the increased focus on R&D.
Oncology segment dominated the overall market owing to the rising cancer incidence worldwide along with an enhanced focus on targeted therapies
Asia Pacific is expected to witness the fastest growth during the forecast period owing to the improved manufacturing facilities and the availability of many generic HPAPI producers

Go through the table of content of API and High Potency API Industry Data Book to get a better understanding of the Coverage & Scope of the study

Competitive Landscape

Competitive rivalry in this market is likely to be high due to increasing interest in small molecules and biologics for the treatment of chronic diseases is attracting industry players. These players have adopted strategies such as acquisitions, collaborations, and expansion of manufacturing units to strengthen their position in the market. Development of targeted therapies over the forecast period is expected to further intensify the competitive rivalry in the market. As part of strategic geographical expansion, many companies are setting up manufacturing plants in Asia Pacific region. In addition, increasing number of companies switch to contract manufacturers for APIs, which is further increasing competitive rivalry.

Key players operating in the API and High Potency API industry are:

Merck & Co., Inc.
AbbVie, Inc.
Bristol-Myers Squibb Company.
Boehringer Ingelheim International GmbH.
Cipla, Inc.
Teva Pharmaceutical Industries Ltd.
Albemarle Corporation
Viatris Inc.
Aurobindo Pharma
Sun Pharmaceutical Industries Ltd.

Check out more Industry Data Books, published by Grand View Research

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Matched content

Editor’s pick